News
Exanta on NICE list ahead of marketing authorisation
Aventis has gone to court in the US to prevent generic versions of its second-biggest drug, blockbuster anti-thrombotic treatment Lovenox, coming to...
Patients would benefit from less involvement between pharmaceutical companies and the medical profession, according to new research.
Doctors in the UK are to vote on the long-awaited GP contract next week, despite calls by GP representatives to delay the ballot by six months.
An increasing disengagement of GPs from their primary care trusts is threatening to thwart the government's plans for an NHS led by frontline...
Roche new mart pillXeloda has been recommended by NICE for the treatment of advanced breast and bowel cancer.
The Government has conceded to intense pressure to give patients input into a new inquiry on the safety of SSRI antidepressants.
Audit of NHS obesity services reveals inequalities